Absci (ABSI) Total Non-Current Liabilities (2020 - 2026)

Absci (ABSI) posted Total Non-Current Liabilities of $22.8 million for Q1 2026, down 11.65% sequentially from $25.8 million in Q4 2025, and down 28.62% YoY from $32.0 million in Q1 2025.

Absci (ABSI) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Absci has reported Total Non-Current Liabilities for 7 years, with the latest figure at $22.8 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 28.62% year-over-year to $22.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.8 million (down 28.62% YoY) and the FY2025 annual result came in at $25.8 million, down 24.8% from the prior year.
  • Total Non-Current Liabilities slipped to $22.8 million in Q1 2026 per ABSI's latest filing, from $25.8 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $54.7 million in Q1 2022 and troughed at $22.8 million in Q1 2026.
  • A 5-year average of $37.9 million and a median of $35.0 million in 2025 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities sank 75.66% in 2022, then increased 2.97% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $46.6 million in 2022, then dropped by 12.31% to $40.8 million in 2023, then fell by 15.88% to $34.3 million in 2024, then decreased by 24.8% to $25.8 million in 2025, then decreased by 11.65% to $22.8 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $22.8 million, $25.8 million, and $32.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 5.92 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 7.74 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 40.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 1.53 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.88 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 9.32 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 4.20 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 1.17 Bn
10 Absci 1.58 Bn 1.37 Bn - 21.48 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 21.48 Mn
Mar 31, 2026 22.82 Mn
Dec 31, 2025 25.83 Mn
Sep 30, 2025 32.87 Mn
Jun 30, 2025 35.04 Mn
Mar 31, 2025 31.97 Mn
Dec 31, 2024 34.34 Mn
Sep 30, 2024 33.87 Mn
Jun 30, 2024 34.03 Mn
Mar 31, 2024 34.71 Mn
Dec 31, 2023 40.83 Mn
Sep 30, 2023 39.93 Mn
Jun 30, 2023 38.75 Mn
Mar 31, 2023 41.84 Mn
Dec 31, 2022 46.56 Mn
Sep 30, 2022 46.41 Mn
Jun 30, 2022 49.90 Mn
Mar 31, 2022 54.74 Mn
Dec 31, 2021 47.93 Mn
Sep 30, 2021 48.98 Mn